Janus Henderson Group’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.9M | Buy |
+3,022,784
| New | +$12.9M | 0.01% | 663 |
|
|
2025
Q1 | – | Sell |
-17,800
| Closed | -$104K | – | 2527 |
|
|
2024
Q4 | $104K | Hold |
17,800
| – | – | ﹤0.01% | 2509 |
|
|
2024
Q3 | $212K | Sell |
17,800
-38,200
| -68% | -$456K | ﹤0.01% | 2414 |
|
|
2024
Q2 | $605K | Sell |
56,000
-1,165,662
| -95% | -$12.6M | ﹤0.01% | 1891 |
|
|
2024
Q1 | $13.8M | Buy |
1,221,662
+521,562
| +74% | +$5.9M | 0.01% | 629 |
|
|
2023
Q4 | $9.81M | Buy |
+700,100
| New | +$9.81M | 0.01% | 673 |
|
|
2023
Q2 | – | Sell |
-2,085,179
| Closed | -$7.28M | – | 2646 |
|
|
2023
Q1 | $7.28M | Sell |
2,085,179
-972,127
| -32% | -$3.39M | ﹤0.01% | 781 |
|
|
2022
Q4 | $7.47M | Sell |
3,057,306
-3,736,068
| -55% | -$9.13M | 0.01% | 778 |
|
|
2022
Q3 | $18.7M | Buy |
6,793,374
+3,472,241
| +105% | +$9.58M | 0.01% | 691 |
|
|
2022
Q2 | $13.5M | Sell |
3,321,133
-236,301
| -7% | -$963K | 0.01% | 629 |
|
|
2022
Q1 | $15.1M | Buy |
3,557,434
+561,994
| +19% | +$2.39M | 0.01% | 805 |
|
|
2021
Q4 | $28M | Buy |
2,995,440
+519,610
| +21% | +$4.86M | 0.01% | 705 |
|
|
2021
Q3 | $68.2M | Sell |
2,475,830
-748,848
| -23% | -$20.6M | 0.03% | 466 |
|
|
2021
Q2 | $90.3M | Sell |
3,224,678
-350,890
| -10% | -$9.82M | 0.04% | 400 |
|
|
2021
Q1 | $114M | Sell |
3,575,568
-63,270
| -2% | -$2.01M | 0.05% | 336 |
|
|
2020
Q4 | $161M | Buy |
+3,638,838
| New | +$161M | 0.07% | 267 |
|